Vaccine-maker Hilleman opens S$27 million facility in Singapore | Video
02:28 Min
A new S$27 million facility by global firm Hilleman Laboratories in Singapore will produce vaccines for any future pandemic. It is the first of its kind in Singapore that can develop a vaccine from start to finish. Sherlyn Seah reports.
09 Nov 2023 10:50pm
A new S$27 million facility by global firm Hilleman Laboratories in Singapore will produce vaccines for any future pandemic. It is the first of its kind in Singapore that can develop a vaccine from start to finish. Sherlyn Seah reports.
Popular Shows
